The WACC of Abionyx Pharma SA (ABNX.PA) is 6.2%.
| Range | Selected | |
| Cost of equity | 5.20% - 7.60% | 6.40% |
| Tax rate | 25.90% - 27.10% | 26.50% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.1% - 7.3% | 6.2% |
| Category | Low | High |
| Long-term bond rate | 3.0% | 3.5% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.37 | 0.52 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.20% | 7.60% |
| Tax rate | 25.90% | 27.10% |
| Debt/Equity ratio | 0.08 | 0.08 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.1% | 7.3% |
| Selected WACC | 6.2% | |